A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironmentsKevin C. Barry, Matthew F. Krummel, Miranda L. Broz et al.|Nature Medicine|2018Cited by 1k
Tumor immune profiling predicts response to anti–PD-1 therapy in human melanomaAdil Daud, Michael D. Rosenblum|Journal of Clinical Investigation|2016Cited by 526